Life technologies corporation:1107072 [19-041601]

Ended Awarded Last action

Contract number
75N91019F00130
Awardee
Awarding agency
Obligated
$43,355

Award facts

Opportunity
Contract value 100% obligated
$43,354.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Grand Island, NY 14072, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a delivery order to Life Technologies Corporation on June 6, 2019, with a ceiling value of $43,354.52 for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers.

Place of performance is Grand Island, NY. The order is firm fixed price with an ultimate completion date of July 6, 2019. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific Inc. and specializes in biomedical research and genetic analysis tools for federal agencies.

Quick answers

Who was awarded contract 75N91019F00130?

75N91019F00130 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on June 6, 2019.

How much is contract 75N91019F00130 worth?

The government has obligated $43,355 on 75N91019F00130.

Is contract 75N91019F00130 an order under another contract?

Yes. 75N91019F00130 is a delivery order under 75N91018D00037, an indefinite delivery contract.

Was contract 75N91019F00130 competed?

The extent of competition for 75N91019F00130 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award